TEVA REPORTS TENTATIVE APPROVAL OF RABEPRAZOLE TABLETS

Teva has announced that the FDA has granted tentative approval for the company's abbreviated new drug application for 20-mg Rabeprazole sodium delayed-release tablets.

Upon final approval, the drug will be the generic equivalent of Eisai's acid pump inhibitor Aciphex tablets.